Primary non-alcoholic fatty liver disease in hypertensive patients

Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular...

Full description

Saved in:
Bibliographic Details
Published in:Australasian medical journal 2013-01, Vol.6 (6), p.325-330
Main Authors: Latea, Luminita, Negrea, Stefania, Bolboaca, Sorana
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-23ff6eea23e353e2034b09b093287a95882c3dd2de194ac0be3cfd4f91131ef13
cites
container_end_page 330
container_issue 6
container_start_page 325
container_title Australasian medical journal
container_volume 6
creator Latea, Luminita
Negrea, Stefania
Bolboaca, Sorana
description Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm. This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca's Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non-dipper (ND), reverse-dipper (RD), and extreme-dipper (ED). All hypertensive patients underwent 24 ABPM, blood tests and abdominal ultrasonography for the diagnosis of fatty liver disease. Thirty-five hypertensive patients were included in the study, with 31.42% ND, 11.43% RD, 8.57% ED and 48.57% D. The prevalence of NAFLD was significantly higher in ND, RD and ED when compared to D. When compared to the dipper group of hypertensive patients a statistically significantly higher level of plasma insulin was observed: in non-dipper [86.3±17.9pmol/l vs. 62.2±203pmol/l, p
doi_str_mv 10.4066/AMJ.2013.1648
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3702137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1399265602</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-23ff6eea23e353e2034b09b093287a95882c3dd2de194ac0be3cfd4f91131ef13</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMottQevcoevWxNMvuRvQi1-ElFD3oOaXZiI9vNutkW-u_N0lrqMDAD8_LOzEPIJaOThGbZzfT1ZcIpgwnLEnFChkxAFrMC0tOjfkDG3n_TEFAUHPg5GXAQkFNBh-TuvbUr1W6j2tWxqrRbusrqyKiu20aV3WAbldaj8hjZOlpuG2w7rH0YRI3qLNadvyBnRlUex_s6Ip8P9x-zp3j-9vg8m85jDSLvYg7GZIiKA0IKyCkkC1qEBC5yVaRCcA1lyUtkRaI0XSBoUyamYAwYGgYjcrvzbdaLFZY67G5VJZvdA9IpK_9ParuUX24jw6ucQR4MrvcGrftZo-_kynqNVaVqdGsvWc8nSzPKgzTeSXXrvG_RHNYwKnv0MqCXPXrZow_6q-PbDuo_0PALVF1_8w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399265602</pqid></control><display><type>article</type><title>Primary non-alcoholic fatty liver disease in hypertensive patients</title><source>PubMed Central</source><creator>Latea, Luminita ; Negrea, Stefania ; Bolboaca, Sorana</creator><creatorcontrib>Latea, Luminita ; Negrea, Stefania ; Bolboaca, Sorana</creatorcontrib><description>Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm. This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca's Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non-dipper (ND), reverse-dipper (RD), and extreme-dipper (ED). All hypertensive patients underwent 24 ABPM, blood tests and abdominal ultrasonography for the diagnosis of fatty liver disease. Thirty-five hypertensive patients were included in the study, with 31.42% ND, 11.43% RD, 8.57% ED and 48.57% D. The prevalence of NAFLD was significantly higher in ND, RD and ED when compared to D. When compared to the dipper group of hypertensive patients a statistically significantly higher level of plasma insulin was observed: in non-dipper [86.3±17.9pmol/l vs. 62.2±203pmol/l, p&lt;0.05], in reverse dipper [88.3±18.6pmol/l vs. 62.2±20.3pmol/l] and in extreme-dippers [86.7±16.88pmol/l vs. 62.2±20.3 pmol/l, p&lt;0.05]. The altered dipping status (ND, RD, ED) of hypertension associated with a higher insulin resistance could be the pathogenetic link between the NAFLD and altered blood pressure status. Altered BP status could be a marker of NAFLD in hypertensive patients.</description><identifier>ISSN: 1836-1935</identifier><identifier>EISSN: 1836-1935</identifier><identifier>DOI: 10.4066/AMJ.2013.1648</identifier><identifier>PMID: 23837080</identifier><language>eng</language><publisher>Canada: Australasian Medical Journal</publisher><ispartof>Australasian medical journal, 2013-01, Vol.6 (6), p.325-330</ispartof><rights>Australasian Medical Journal 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-23ff6eea23e353e2034b09b093287a95882c3dd2de194ac0be3cfd4f91131ef13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702137/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702137/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23837080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Latea, Luminita</creatorcontrib><creatorcontrib>Negrea, Stefania</creatorcontrib><creatorcontrib>Bolboaca, Sorana</creatorcontrib><title>Primary non-alcoholic fatty liver disease in hypertensive patients</title><title>Australasian medical journal</title><addtitle>Australas Med J</addtitle><description>Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm. This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca's Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non-dipper (ND), reverse-dipper (RD), and extreme-dipper (ED). All hypertensive patients underwent 24 ABPM, blood tests and abdominal ultrasonography for the diagnosis of fatty liver disease. Thirty-five hypertensive patients were included in the study, with 31.42% ND, 11.43% RD, 8.57% ED and 48.57% D. The prevalence of NAFLD was significantly higher in ND, RD and ED when compared to D. When compared to the dipper group of hypertensive patients a statistically significantly higher level of plasma insulin was observed: in non-dipper [86.3±17.9pmol/l vs. 62.2±203pmol/l, p&lt;0.05], in reverse dipper [88.3±18.6pmol/l vs. 62.2±20.3pmol/l] and in extreme-dippers [86.7±16.88pmol/l vs. 62.2±20.3 pmol/l, p&lt;0.05]. The altered dipping status (ND, RD, ED) of hypertension associated with a higher insulin resistance could be the pathogenetic link between the NAFLD and altered blood pressure status. Altered BP status could be a marker of NAFLD in hypertensive patients.</description><issn>1836-1935</issn><issn>1836-1935</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMottQevcoevWxNMvuRvQi1-ElFD3oOaXZiI9vNutkW-u_N0lrqMDAD8_LOzEPIJaOThGbZzfT1ZcIpgwnLEnFChkxAFrMC0tOjfkDG3n_TEFAUHPg5GXAQkFNBh-TuvbUr1W6j2tWxqrRbusrqyKiu20aV3WAbldaj8hjZOlpuG2w7rH0YRI3qLNadvyBnRlUex_s6Ip8P9x-zp3j-9vg8m85jDSLvYg7GZIiKA0IKyCkkC1qEBC5yVaRCcA1lyUtkRaI0XSBoUyamYAwYGgYjcrvzbdaLFZY67G5VJZvdA9IpK_9ParuUX24jw6ucQR4MrvcGrftZo-_kynqNVaVqdGsvWc8nSzPKgzTeSXXrvG_RHNYwKnv0MqCXPXrZow_6q-PbDuo_0PALVF1_8w</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Latea, Luminita</creator><creator>Negrea, Stefania</creator><creator>Bolboaca, Sorana</creator><general>Australasian Medical Journal</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Primary non-alcoholic fatty liver disease in hypertensive patients</title><author>Latea, Luminita ; Negrea, Stefania ; Bolboaca, Sorana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-23ff6eea23e353e2034b09b093287a95882c3dd2de194ac0be3cfd4f91131ef13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Latea, Luminita</creatorcontrib><creatorcontrib>Negrea, Stefania</creatorcontrib><creatorcontrib>Bolboaca, Sorana</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Australasian medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Latea, Luminita</au><au>Negrea, Stefania</au><au>Bolboaca, Sorana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary non-alcoholic fatty liver disease in hypertensive patients</atitle><jtitle>Australasian medical journal</jtitle><addtitle>Australas Med J</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>6</volume><issue>6</issue><spage>325</spage><epage>330</epage><pages>325-330</pages><issn>1836-1935</issn><eissn>1836-1935</eissn><abstract>Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm. This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca's Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non-dipper (ND), reverse-dipper (RD), and extreme-dipper (ED). All hypertensive patients underwent 24 ABPM, blood tests and abdominal ultrasonography for the diagnosis of fatty liver disease. Thirty-five hypertensive patients were included in the study, with 31.42% ND, 11.43% RD, 8.57% ED and 48.57% D. The prevalence of NAFLD was significantly higher in ND, RD and ED when compared to D. When compared to the dipper group of hypertensive patients a statistically significantly higher level of plasma insulin was observed: in non-dipper [86.3±17.9pmol/l vs. 62.2±203pmol/l, p&lt;0.05], in reverse dipper [88.3±18.6pmol/l vs. 62.2±20.3pmol/l] and in extreme-dippers [86.7±16.88pmol/l vs. 62.2±20.3 pmol/l, p&lt;0.05]. The altered dipping status (ND, RD, ED) of hypertension associated with a higher insulin resistance could be the pathogenetic link between the NAFLD and altered blood pressure status. Altered BP status could be a marker of NAFLD in hypertensive patients.</abstract><cop>Canada</cop><pub>Australasian Medical Journal</pub><pmid>23837080</pmid><doi>10.4066/AMJ.2013.1648</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1836-1935
ispartof Australasian medical journal, 2013-01, Vol.6 (6), p.325-330
issn 1836-1935
1836-1935
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3702137
source PubMed Central
title Primary non-alcoholic fatty liver disease in hypertensive patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A07%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20non-alcoholic%20fatty%20liver%20disease%20in%20hypertensive%20patients&rft.jtitle=Australasian%20medical%20journal&rft.au=Latea,%20Luminita&rft.date=2013-01-01&rft.volume=6&rft.issue=6&rft.spage=325&rft.epage=330&rft.pages=325-330&rft.issn=1836-1935&rft.eissn=1836-1935&rft_id=info:doi/10.4066/AMJ.2013.1648&rft_dat=%3Cproquest_pubme%3E1399265602%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-23ff6eea23e353e2034b09b093287a95882c3dd2de194ac0be3cfd4f91131ef13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1399265602&rft_id=info:pmid/23837080&rfr_iscdi=true